Abstract
Recently, several new users have appeared on the market using applications to significantly reduce infectious disease mortality. Regarding pneumococci that have WHO priority, much attention is also given to vaccination against rotaviruses and papillomaviruses.
Rotavirus candidates Rotarix and RotaTeqili sosi in the European Union in 2006 and May 2007 at the ESPID congress in Portugal issued recommendations of two European pediatric societies (ESPID and ESPGHAN) Currently vaccinated across Austria, Luxembourg, Belgium, vaccination is also in preparation Germany and other European countries. Outside Europe, they are generally vaccinated with children in the USA and Australia.